R J BIO-TECH | INDO US BIO-TECH | R J BIO-TECH/ INDO US BIO-TECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 40.7 | - | View Chart |
P/BV | x | - | 8.3 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
R J BIO-TECH INDO US BIO-TECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
INDO US BIO-TECH Mar-23 |
R J BIO-TECH/ INDO US BIO-TECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 125 | 9.5% | |
Low | Rs | 5 | 25 | 20.5% | |
Sales per share (Unadj.) | Rs | 14.7 | 61.6 | 23.8% | |
Earnings per share (Unadj.) | Rs | -4.3 | 7.2 | -59.2% | |
Cash flow per share (Unadj.) | Rs | -4.2 | 8.0 | -52.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.2 | 54.3 | -97.8% | |
Shares outstanding (eoy) | m | 9.47 | 10.03 | 94.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 1.2 | 47.6% | |
Avg P/E ratio | x | -2.0 | 10.4 | -19.2% | |
P/CF ratio (eoy) | x | -2.0 | 9.4 | -21.7% | |
Price / Book Value ratio | x | -0.2 | 1.4 | -11.6% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 81 | 754 | 10.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 13 | 45.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 617 | 22.5% | |
Other income | Rs m | 7 | 0 | 3,209.5% | |
Total revenues | Rs m | 146 | 618 | 23.6% | |
Gross profit | Rs m | 12 | 94 | 12.4% | |
Depreciation | Rs m | 1 | 8 | 8.1% | |
Interest | Rs m | 58 | 12 | 484.8% | |
Profit before tax | Rs m | -40 | 74 | -54.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 1 | 0.0% | |
Profit after tax | Rs m | -40 | 72 | -55.9% | |
Gross profit margin | % | 8.4 | 15.2 | 55.1% | |
Effective tax rate | % | 0 | 2.0 | -0.0% | |
Net profit margin | % | -29.1 | 11.7 | -248.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 599 | 0.5% | |
Current liabilities | Rs m | 484 | 123 | 393.3% | |
Net working cap to sales | % | -345.9 | 77.1 | -448.5% | |
Current ratio | x | 0 | 4.9 | 0.1% | |
Inventory Days | Days | 3 | 1 | 185.1% | |
Debtors Days | Days | 7,265,677 | 146,261,410 | 5.0% | |
Net fixed assets | Rs m | 16 | 90 | 18.1% | |
Share capital | Rs m | 95 | 100 | 94.4% | |
"Free" reserves | Rs m | -598 | 445 | -134.5% | |
Net worth | Rs m | -503 | 545 | -92.4% | |
Long term debt | Rs m | 33 | 17 | 194.5% | |
Total assets | Rs m | 19 | 689 | 2.8% | |
Interest coverage | x | 0.3 | 7.2 | 4.3% | |
Debt to equity ratio | x | -0.1 | 0 | -210.6% | |
Sales to assets ratio | x | 7.2 | 0.9 | 807.9% | |
Return on assets | % | 92.4 | 12.3 | 753.8% | |
Return on equity | % | 8.0 | 13.3 | 60.5% | |
Return on capital | % | -3.8 | 15.3 | -24.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 2.5 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 4 | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 4 | 0 | - | |
Net fx | Rs m | -4 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | 5 | -896.8% | |
From Investments | Rs m | NA | -67 | -0.0% | |
From Financial Activity | Rs m | 47 | 63 | 74.4% | |
Net Cashflow | Rs m | 0 | 1 | -27.7% |
Indian Promoters | % | 60.3 | 70.2 | 86.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 29.8 | 133.0% | |
Shareholders | 245 | 1,166 | 21.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | INDO US BIO-TECH | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | -3.83% | 0.01% |
1-Month | 1.48% | -3.42% | 1.42% |
1-Year | -26.39% | 113.21% | 13.97% |
3-Year CAGR | -24.59% | 149.32% | 15.82% |
5-Year CAGR | -25.99% | 41.05% | 10.78% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the INDO US BIO-TECH share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of INDO US BIO-TECH the stake stands at 70.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of INDO US BIO-TECH.
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
INDO US BIO-TECH paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of INDO US BIO-TECH.
For a sector overview, read our fmcg sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.